4/A
Changes in Ownership
MANNKIND CORP Filed Acc 0001209191-22-047428
EVP Endocrine Business Unit acquired 36,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Galindo Alejandro EVP Endocrine Business Unit | 2022-02-28 | Grant or award | +36,900 | $2.71 | $99,999 | 576,690 | D: show line 1 in the form |
Loading xslF345X03/doc4a.xml…